JP2022553284A5 - - Google Patents
Info
- Publication number
- JP2022553284A5 JP2022553284A5 JP2022523359A JP2022523359A JP2022553284A5 JP 2022553284 A5 JP2022553284 A5 JP 2022553284A5 JP 2022523359 A JP2022523359 A JP 2022523359A JP 2022523359 A JP2022523359 A JP 2022523359A JP 2022553284 A5 JP2022553284 A5 JP 2022553284A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- membered
- optionally substituted
- halogen
- pyridyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962925475P | 2019-10-24 | 2019-10-24 | |
| US62/925,475 | 2019-10-24 | ||
| PCT/JP2020/039994 WO2021080013A1 (en) | 2019-10-24 | 2020-10-23 | Inhibitors of trek (twik related k+ channels) channel function |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022553284A JP2022553284A (ja) | 2022-12-22 |
| JP2022553284A5 true JP2022553284A5 (enExample) | 2023-10-06 |
Family
ID=75620729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523359A Ceased JP2022553284A (ja) | 2019-10-24 | 2020-10-23 | Trek(twik関連k+チャネル)チャネル機能の阻害剤 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20240190824A1 (enExample) |
| EP (1) | EP4048399A4 (enExample) |
| JP (1) | JP2022553284A (enExample) |
| WO (1) | WO2021080013A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2026521154A (ja) * | 2023-06-13 | 2026-06-26 | 小野薬品工業株式会社 | Trek(twik関連k+チャネル)チャネル機能の阻害剤 |
| WO2026034972A1 (ko) * | 2024-08-06 | 2026-02-12 | 주식회사 비보존 | Mglur5 및 hdac6의 이중 조절제 및 이의 용도 |
| WO2026130316A1 (en) * | 2024-12-17 | 2026-06-25 | Ono Pharmaceutical Co., Ltd. | Inhibitors of trek (twik related k+ channels) channel function |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006515838A (ja) * | 2002-11-22 | 2006-06-08 | スミスクライン ビーチャム コーポレーション | ファルネソイドx受容体アゴニスト |
| EP1765379A4 (en) | 2004-06-17 | 2009-05-27 | Transform Pharmaceuticals Inc | PHARMACEUTICAL CO-CRYSTAL COMPOSITIONS AND RELEVANT USE METHOD |
| GB0614691D0 (en) * | 2006-07-24 | 2006-08-30 | Syngenta Participations Ag | Insecticidal compounds |
| EP1894924A1 (en) * | 2006-08-29 | 2008-03-05 | Phenex Pharmaceuticals AG | Heterocyclic FXR binding compounds |
| KR20120049852A (ko) * | 2009-06-30 | 2012-05-17 | 시가 테크놀로지스, 인크. | 뎅기 바이러스 감염의 치료 및 예방 |
| EP2968270A4 (en) * | 2013-03-14 | 2016-08-17 | Univ California | MODULATION OF K2P CHANNELS |
| WO2014210319A2 (en) * | 2013-06-26 | 2014-12-31 | The Trustees Of Columbia University In The City Of New York | Inhibitors of plasmodium falciparum equilibrative nucleoside transporter type 1 as anti-parasitic compounds |
| EP3558992A4 (en) * | 2016-12-15 | 2020-12-02 | ONO Pharmaceutical Co., Ltd. | TREK CHANNEL ACTIVATOR (K + CHANNELS ASSOCIATED WITH TWIK) |
| US11208407B2 (en) * | 2017-08-02 | 2021-12-28 | Merck Sharp & Dohme Corp. | Substituted phenyl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors |
-
2020
- 2020-10-23 US US17/769,300 patent/US20240190824A1/en not_active Abandoned
- 2020-10-23 JP JP2022523359A patent/JP2022553284A/ja not_active Ceased
- 2020-10-23 WO PCT/JP2020/039994 patent/WO2021080013A1/en not_active Ceased
- 2020-10-23 EP EP20880270.2A patent/EP4048399A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12458642B2 (en) | Metalloenzyme inhibitor compounds | |
| JP6163205B2 (ja) | 補体経路モジュレーターおよびその使用 | |
| US9199979B2 (en) | Thiazolylphenyl-benzenesulfonamido derivatives as kinase inhibitors | |
| JP2021535134A5 (enExample) | ||
| CN106029064B (zh) | 治疗化合物和组合物 | |
| JP2022552655A5 (enExample) | ||
| JP6509897B2 (ja) | 抗真菌化合物の調製方法 | |
| TW201840556A (zh) | 金屬酶抑制劑化合物、醫藥組成物及使用該金屬酶抑制劑化合物之方法 | |
| JP2011500563A (ja) | ジフェニル置換されたシクロアルカン | |
| JP2022538774A5 (enExample) | ||
| WO2002006237A1 (en) | Medicine comprising dicyanopyridine derivative | |
| JP2021535137A5 (enExample) | ||
| RU2018104868A (ru) | 2-амино-3-фтор-3-(фторметил)-6-метил-6-фенил-3,4,5,6-тетрагидропиридины в качестве ингибиторов bace1 | |
| JP2023510971A5 (enExample) | ||
| AU2006227199A1 (en) | Beta-lactamylalkanoic acids for treating premenstrual disorders | |
| JP2022543859A5 (enExample) | ||
| KR20060128950A (ko) | 아미도피라졸 유도체 | |
| CA3233410A1 (en) | Benzimidazoles as modulators of il-17 | |
| JP2009501745A5 (enExample) | ||
| US11465994B2 (en) | MGluR7 agonist compounds for treating mGluR7-regulated diseases, disorders, or conditions | |
| JP2009511589A5 (enExample) | ||
| JP2013533233A (ja) | Ccr2のシクロヘキシル−アゼチジニルアンタゴニスト | |
| CN104583198A (zh) | 新吡啶衍生物 | |
| JP2019508390A (ja) | mGluR7調節薬としてのインダン誘導体 | |
| JP2024517504A (ja) | アゼチジン環状尿素を含めたrip1調節物質、その調製、及び使用 |